118 related articles for article (PubMed ID: 36862804)
21. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers.
Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM
JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023
[TBL] [Abstract][Full Text] [Related]
22. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities.
Craig DW; O'Shaughnessy JA; Kiefer JA; Aldrich J; Sinari S; Moses TM; Wong S; Dinh J; Christoforides A; Blum JL; Aitelli CL; Osborne CR; Izatt T; Kurdoglu A; Baker A; Koeman J; Barbacioru C; Sakarya O; De La Vega FM; Siddiqui A; Hoang L; Billings PR; Salhia B; Tolcher AW; Trent JM; Mousses S; Von Hoff D; Carpten JD
Mol Cancer Ther; 2013 Jan; 12(1):104-16. PubMed ID: 23171949
[TBL] [Abstract][Full Text] [Related]
23. The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor-Positive Metastatic Breast Cancer.
Wander SA; Cohen O; Gong X; Johnson GN; Buendia-Buendia JE; Lloyd MR; Kim D; Luo F; Mao P; Helvie K; Kowalski KJ; Nayar U; Waks AG; Parsons SH; Martinez R; Litchfield LM; Ye XS; Yu C; Jansen VM; Stille JR; Smith PS; Oakley GJ; Chu QS; Batist G; Hughes ME; Kremer JD; Garraway LA; Winer EP; Tolaney SM; Lin NU; Buchanan SG; Wagle N
Cancer Discov; 2020 Aug; 10(8):1174-1193. PubMed ID: 32404308
[TBL] [Abstract][Full Text] [Related]
24. Whole-genome and transcriptome analysis enhances precision cancer treatment options.
Pleasance E; Bohm A; Williamson LM; Nelson JMT; Shen Y; Bonakdar M; Titmuss E; Csizmok V; Wee K; Hosseinzadeh S; Grisdale CJ; Reisle C; Taylor GA; Lewis E; Jones MR; Bleile D; Sadeghi S; Zhang W; Davies A; Pellegrini B; Wong T; Bowlby R; Chan SK; Mungall KL; Chuah E; Mungall AJ; Moore RA; Zhao Y; Deol B; Fisic A; Fok A; Regier DA; Weymann D; Schaeffer DF; Young S; Yip S; Schrader K; Levasseur N; Taylor SK; Feng X; Tinker A; Savage KJ; Chia S; Gelmon K; Sun S; Lim H; Renouf DJ; Jones SJM; Marra MA; Laskin J
Ann Oncol; 2022 Sep; 33(9):939-949. PubMed ID: 35691590
[TBL] [Abstract][Full Text] [Related]
25. Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes.
Pleasance E; Titmuss E; Williamson L; Kwan H; Culibrk L; Zhao EY; Dixon K; Fan K; Bowlby R; Jones MR; Shen Y; Grewal JK; Ashkani J; Wee K; Grisdale CJ; Thibodeau ML; Bozoky Z; Pearson H; Majounie E; Vira T; Shenwai R; Mungall KL; Chuah E; Davies A; Warren M; Reisle C; Bonakdar M; Taylor GA; Csizmok V; Chan SK; Zong Z; Bilobram S; Muhammadzadeh A; D'Souza D; Corbett RD; MacMillan D; Carreira M; Choo C; Bleile D; Sadeghi S; Zhang W; Wong T; Cheng D; Brown SD; Holt RA; Moore RA; Mungall AJ; Zhao Y; Nelson J; Fok A; Ma Y; Lee MKC; Lavoie JM; Mendis S; Karasinska JM; Deol B; Fisic A; Schaeffer DF; Yip S; Schrader K; Regier DA; Weymann D; Chia S; Gelmon K; Tinker A; Sun S; Lim H; Renouf DJ; Laskin J; Jones SJM; Marra MA
Nat Cancer; 2020 Apr; 1(4):452-468. PubMed ID: 35121966
[TBL] [Abstract][Full Text] [Related]
26. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.
Nguyen B; Fong C; Luthra A; Smith SA; DiNatale RG; Nandakumar S; Walch H; Chatila WK; Madupuri R; Kundra R; Bielski CM; Mastrogiacomo B; Donoghue MTA; Boire A; Chandarlapaty S; Ganesh K; Harding JJ; Iacobuzio-Donahue CA; Razavi P; Reznik E; Rudin CM; Zamarin D; Abida W; Abou-Alfa GK; Aghajanian C; Cercek A; Chi P; Feldman D; Ho AL; Iyer G; Janjigian YY; Morris M; Motzer RJ; O'Reilly EM; Postow MA; Raj NP; Riely GJ; Robson ME; Rosenberg JE; Safonov A; Shoushtari AN; Tap W; Teo MY; Varghese AM; Voss M; Yaeger R; Zauderer MG; Abu-Rustum N; Garcia-Aguilar J; Bochner B; Hakimi A; Jarnagin WR; Jones DR; Molena D; Morris L; Rios-Doria E; Russo P; Singer S; Strong VE; Chakravarty D; Ellenson LH; Gopalan A; Reis-Filho JS; Weigelt B; Ladanyi M; Gonen M; Shah SP; Massague J; Gao J; Zehir A; Berger MF; Solit DB; Bakhoum SF; Sanchez-Vega F; Schultz N
Cell; 2022 Feb; 185(3):563-575.e11. PubMed ID: 35120664
[TBL] [Abstract][Full Text] [Related]
27. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.
Bagaev A; Kotlov N; Nomie K; Svekolkin V; Gafurov A; Isaeva O; Osokin N; Kozlov I; Frenkel F; Gancharova O; Almog N; Tsiper M; Ataullakhanov R; Fowler N
Cancer Cell; 2021 Jun; 39(6):845-865.e7. PubMed ID: 34019806
[TBL] [Abstract][Full Text] [Related]
28. A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms.
Szikriszt B; Póti Á; Németh E; Kanu N; Swanton C; Szüts D
Mutagenesis; 2021 Apr; 36(1):75-86. PubMed ID: 33502495
[TBL] [Abstract][Full Text] [Related]
29. Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy.
Recondo G; Mahjoubi L; Maillard A; Loriot Y; Bigot L; Facchinetti F; Bahleda R; Gazzah A; Hollebecque A; Mezquita L; Planchard D; Naltet C; Lavaud P; Lacroix L; Richon C; Lovergne AA; De Baere T; Tselikas L; Deas O; Nicotra C; Ngo-Camus M; Frias RL; Solary E; Angevin E; Eggermont A; Olaussen KA; Vassal G; Michiels S; Andre F; Scoazec JY; Massard C; Soria JC; Besse B; Friboulet L
NPJ Precis Oncol; 2020; 4():27. PubMed ID: 32964129
[TBL] [Abstract][Full Text] [Related]
30. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Marabelle A; Fakih M; Lopez J; Shah M; Shapira-Frommer R; Nakagawa K; Chung HC; Kindler HL; Lopez-Martin JA; Miller WH; Italiano A; Kao S; Piha-Paul SA; Delord JP; McWilliams RR; Fabrizio DA; Aurora-Garg D; Xu L; Jin F; Norwood K; Bang YJ
Lancet Oncol; 2020 Oct; 21(10):1353-1365. PubMed ID: 32919526
[TBL] [Abstract][Full Text] [Related]
31. Pervasive chromosomal instability and karyotype order in tumour evolution.
Watkins TBK; Lim EL; Petkovic M; Elizalde S; Birkbak NJ; Wilson GA; Moore DA; Grönroos E; Rowan A; Dewhurst SM; Demeulemeester J; Dentro SC; Horswell S; Au L; Haase K; Escudero M; Rosenthal R; Bakir MA; Xu H; Litchfield K; Lu WT; Mourikis TP; Dietzen M; Spain L; Cresswell GD; Biswas D; Lamy P; Nordentoft I; Harbst K; Castro-Giner F; Yates LR; Caramia F; Jaulin F; Vicier C; Tomlinson IPM; Brastianos PK; Cho RJ; Bastian BC; Dyrskjøt L; Jönsson GB; Savas P; Loi S; Campbell PJ; Andre F; Luscombe NM; Steeghs N; Tjan-Heijnen VCG; Szallasi Z; Turajlic S; Jamal-Hanjani M; Van Loo P; Bakhoum SF; Schwarz RF; McGranahan N; Swanton C
Nature; 2020 Nov; 587(7832):126-132. PubMed ID: 32879494
[TBL] [Abstract][Full Text] [Related]
32. Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes.
Wang Q; Pierce-Hoffman E; Cummings BB; Alföldi J; Francioli LC; Gauthier LD; Hill AJ; O'Donnell-Luria AH; ; ; Karczewski KJ; MacArthur DG
Nat Commun; 2020 May; 11(1):2539. PubMed ID: 32461613
[TBL] [Abstract][Full Text] [Related]
33. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases.
Hu Z; Li Z; Ma Z; Curtis C
Nat Genet; 2020 Jul; 52(7):701-708. PubMed ID: 32424352
[TBL] [Abstract][Full Text] [Related]
34. Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma.
Feng JF; Wang L; Yang X; Chen S
J Cancer; 2020; 11(6):1334-1340. PubMed ID: 32047540
[No Abstract] [Full Text] [Related]
35. The repertoire of mutational signatures in human cancer.
Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
[TBL] [Abstract][Full Text] [Related]
36. Identification of cancer driver genes based on nucleotide context.
Dietlein F; Weghorn D; Taylor-Weiner A; Richters A; Reardon B; Liu D; Lander ES; Van Allen EM; Sunyaev SR
Nat Genet; 2020 Feb; 52(2):208-218. PubMed ID: 32015527
[TBL] [Abstract][Full Text] [Related]
37. Chromosome arm aneuploidies shape tumour evolution and drug response.
Shukla A; Nguyen THM; Moka SB; Ellis JJ; Grady JP; Oey H; Cristino AS; Khanna KK; Kroese DP; Krause L; Dray E; Fink JL; Duijf PHG
Nat Commun; 2020 Jan; 11(1):449. PubMed ID: 31974379
[TBL] [Abstract][Full Text] [Related]
38. The landscape of chimeric RNAs in non-diseased tissues and cells.
Singh S; Qin F; Kumar S; Elfman J; Lin E; Pham LP; Yang A; Li H
Nucleic Acids Res; 2020 Feb; 48(4):1764-1778. PubMed ID: 31965184
[TBL] [Abstract][Full Text] [Related]
39. Benchmark of long non-coding RNA quantification for RNA sequencing of cancer samples.
Zheng H; Brennan K; Hernaez M; Gevaert O
Gigascience; 2019 Dec; 8(12):. PubMed ID: 31808800
[TBL] [Abstract][Full Text] [Related]
40. ChiTaRS 5.0: the comprehensive database of chimeric transcripts matched with druggable fusions and 3D chromatin maps.
Balamurali D; Gorohovski A; Detroja R; Palande V; Raviv-Shay D; Frenkel-Morgenstern M
Nucleic Acids Res; 2020 Jan; 48(D1):D825-D834. PubMed ID: 31747015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
